Welcome!

News Feed Item

FDA Approval Process for Medical Devices - Updated Programme Includes all the Current FDA Guidelines (Seminar, London)

DUBLIN, April 10, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/t45c8d/fda_approval) has announced the addition of the "FDA Approval Process for Medical Devices - Updated Programme Includes all the Current FDA Guidelines (Seminar, London)"conference to their offering. 

     (Photo: http://photos.prnewswire.com/prnh/20130307/600769 )

The FDA Approval Process for Medical Devices seminar will take place on the 19th & 20th May 2014 at The Rembrandt Hotel, London

This seminar will highlight new changes in the medical device regulations and provide an overview of the submission of documents to the FDA for approval of medical device products. Participants will gain a better understanding of the medical device approval process and the underlying scientific and regulatory principles involved. Guidelines for each aspect of research will be provided, as well as information on the structuring of submissions and post-approval documents. Information on maintaining ongoing relationships with the FDA will also be discussed. Attendance at this seminar will enable delegates to provide the FDA with the necessary information to obtain product approval.

Upon completion of this seminar, participants will:

- Understand the FDA medical device approval system

- Know what is required for an Investigational Device Exemption (IDE)

- Learn the contents of a Post-Market Approval (PMA)

- Discover what to include in an annual report

WHO SHOULD ATTEND

This seminar is intended for Regulatory, Technical and Quality Personnel who require an understanding of the FDA medical device approval system. Management, Legal and other personnel who must be familiar with the essentials of the medical device approval process and submission of related documents will also benefit in attending.

DOCUMENTATION

Delegates will receive a course material folder containing comprehensive documentation provided by the speaker, which will be a valuable source of reference for the future.

A Certificate of Attendance for Professional Development will be given to each participant who completes each course

DATES:

19 & 20 May 2014 

TIMES:

19 May 2014 Start 09.30 - Finish 17.00
20 May 2014 Start 09.00 - Finish 16.30

REGISTRATION & COFFEE

19 May 2014 09.00

VENUE & ACCOMMODATION

The Rembrandt Hotel, 11 Thurloe Place, London SW7 2RS

DIRECTIONS:

Opposite V&A Museum. Nearest underground station: South Kensington.

NOTE: Events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged 

Key Topics Covered: 

PROGRAMME DAY ONE - 19 May 2014 

Introduction to FDA

- History and law
- Definitions
- Overview of FDA
- Establishment registration
- Product licensing


510(k) Process

- Substantial equivalence
- Letter of notification
- Truthful and accurate statements
- Cover page
- Table of contents
- Checklist for filing
- Executive summary
- Intended use
- Device description
- Table of comparison
- Similarities and differences
- Environmental testing
- Comparative performance
- Clinical performance
- Software
- Biocompatibility
- Voluntary standards
- Sterility
- Reusable or single-use device control
- Labelling
- Kit information
- 510(k) summary
- FDA 510(k) review

PROGRAMME DAY TWO - 20 May 2014

Investigational Device Exemption (IDE)

- Significant risk versus non-significant risk
- Sponsor
- Prior investigations and investigational plan
- Facilities and controls
- Investigator agreement
- IRB
- Institutions
- Sale of device
- Environmental assessment
- Labelling
- Informed consent
- GCP
- FDA actions on applications



Pre-Market Approval (PMA)

- Applicant
- Table of contents and summary
- Device description
- Standards
- Non-clinical studies and clinical studies
- One investigator
- Bibliography
- Samples
- Labelling
- Environmental assessment
- PMA amendments and PMA supplements
- FDA action on PMA
- Post-approval requirements 


Speakers

Albert. A Ghignone, MS, RAC, FDA Regulatory, Quality and Clinical Consultant, AAG Incorporated, USA. He has spent more than 30 years in the pharmaceutical industry at Sterling Drugs, Carter-Wallace, Hoechst-Roussel, National Patient Development Corporation and Datascope Corporation. He has a background in pharmacy and dosage form development. 

His professional career has specifically focused in the areas ofregulatory affairs, quality assurance and clinical affairs. He has expertise in dealing with all aspects of the FDA approval process for drugs, biologics and medical devices. In his various positions he was responsible for all regulatory submissions, registrations, FDA liaison and all compliance activities. He also has expertise in the assessment of product and facilities for the due diligence relative to FDA requirements. He lectures throughout the world on drugs, biologics, medical devices and FDA related matters. 

He is a member of the Regulatory Affairs Professional Society, which gave him the Professional of the Year award in 1984. He has served the society as Vice-President, President and Chairman of the Board of Directors. He is certified as both an ISO 9000 Lead Auditor and Regulatory Affairs Professional.

NOTE: Events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged

For more information visit http://www.researchandmarkets.com/research/t45c8d/fda_approval

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
New Relic, Inc. has announced a set of new features across the New Relic Software Analytics Cloud that offer IT operations teams increased visibility, and the ability to diagnose and resolve performance problems quickly. The new features further IT operations teams’ ability to leverage data and analytics, as well as drive collaboration and a common, shared understanding between teams. Software teams are under pressure to resolve performance issues quickly and improve availability, as the comple...
The proper isolation of resources is essential for multi-tenant environments. The traditional approach to isolate resources is, however, rather heavyweight. In his session at 18th Cloud Expo, Igor Drobiazko, co-founder of elastic.io, will draw upon their own experience with operating a Docker container-based infrastructure on a large scale and present a lightweight solution for resource isolation using microservices. He will also discuss the implementation of microservices in data and applicat...
Join IBM June 8 at 18th Cloud Expo at the Javits Center in New York City, NY, and learn how to innovate like a startup and scale for the enterprise. You need to deliver quality applications faster and cheaper, attract and retain customers with an engaging experience across devices, and seamlessly integrate your enterprise systems. And you can't take 12 months to do it.
See storage differently! Storage performance problems have only gotten worse and harder to solve as applications have become largely virtualized and moved to a cloud-based infrastructure. Storage performance in a virtualized environment is not just about IOPS, it is about how well that potential performance is guaranteed to individual VMs for these apps as the number of VMs keep going up real time. In his session at 18th Cloud Expo, Dhiraj Sehgal, in product and marketing at Tintri, will discu...
Machine Learning helps make complex systems more efficient. By applying advanced Machine Learning techniques such as Cognitive Fingerprinting, wind project operators can utilize these tools to learn from collected data, detect regular patterns, and optimize their own operations. In his session at 18th Cloud Expo, Stuart Gillen, Director of Business Development at SparkCognition, will discuss how research has demonstrated the value of Machine Learning in delivering next generation analytics to im...
This is not a small hotel event. It is also not a big vendor party where politicians and entertainers are more important than real content. This is Cloud Expo, the world's longest-running conference and exhibition focused on Cloud Computing and all that it entails. If you want serious presentations and valuable insight about Cloud Computing for three straight days, then register now for Cloud Expo.
As you respond to increasing requests for new analytics, you need fast and flexible technology in your arsenal so that you can deploy the right workload to the right platform for the need at hand. Do you need self-service and fast time to value? Do you have data and application control and privacy needs, along with strict SLAs to meet? IBM dashDB™ is data warehouse technology powered by in-memory computing and in-database analytics that are designed for fast results, scalability and more.
You think you know what’s in your data. But do you? Most organizations are now aware of the business intelligence represented by their data. Data science stands to take this to a level you never thought of – literally. The techniques of data science, when used with the capabilities of Big Data technologies, can make connections you had not yet imagined, helping you discover new insights and ask new questions of your data. In his session at @ThingsExpo, Sarbjit Sarkaria, data science team lead ...
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
So, you bought into the current machine learning craze and went on to collect millions/billions of records from this promising new data source. Now, what do you do with them? Too often, the abundance of data quickly turns into an abundance of problems. How do you extract that "magic essence" from your data without falling into the common pitfalls? In her session at @ThingsExpo, Natalia Ponomareva, Software Engineer at Google, will provide tips on how to be successful in large scale machine lear...
IoT device adoption is growing at staggering rates, and with it comes opportunity for developers to meet consumer demand for an ever more connected world. Wireless communication is the key part of the encompassing components of any IoT device. Wireless connectivity enhances the device utility at the expense of ease of use and deployment challenges. Since connectivity is fundamental for IoT device development, engineers must understand how to overcome the hurdles inherent in incorporating multipl...
Up until last year, enterprises that were looking into cloud services usually undertook a long-term pilot with one of the large cloud providers, running test and dev workloads in the cloud. With cloud’s transition to mainstream adoption in 2015, and with enterprises migrating more and more workloads into the cloud and in between public and private environments, the single-provider approach must be revisited. In his session at 18th Cloud Expo, Yoav Mor, multi-cloud solution evangelist at Cloudy...
We’ve worked with dozens of early adopters across numerous industries and will debunk common misperceptions, which starts with understanding that many of the connected products we’ll use over the next 5 years are already products, they’re just not yet connected. With an IoT product, time-in-market provides much more essential feedback than ever before. Innovation comes from what you do with the data that the connected product provides in order to enhance the customer experience and optimize busi...
The IETF draft standard for M2M certificates is a security solution specifically designed for the demanding needs of IoT/M2M applications. In his session at @ThingsExpo, Brian Romansky, VP of Strategic Technology at TrustPoint Innovation, will explain how M2M certificates can efficiently enable confidentiality, integrity, and authenticity on highly constrained devices.
The paradigm has shifted. A Gartner survey shows that 43% of organizations are using or plan to implement the Internet of Things in 2016. However, not just a handful of companies are still using the old-style ad-hoc trial-and-error ways, unaware of the critical barriers, paint points, traps, and hidden roadblocks. How can you become a winner? In his session at @ThingsExpo, Tony Shan will present a methodical approach to guide the holistic adoption and enablement of IoT implementations. This ov...